My Abstract Submissions

My Author Disclosure Submissions

TITLE OF ABSTRACT:SLIT-tablet mono vs polysensitized

AUTHOR NAME:

Stephen Durham

AUTHOR NAME:

Stephen Durham

TITLE OF ABSTRACT:

SLIT-tablet mono vs polysensitized

Please complete

PLEASE COMPLETE ALL SECTIONS AND SIGN BELOW

Affiliations, if any:

I have/had an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization. Complete the section below as it applies to you during the past two calendar years. Please indicate the commercial organization(s) with which you have/had affiliations, and briefly explain what connection you have/had with the organization. You must disclose this information to your audience

I have/had an affiliation

Complete the section below as it applies to you during the past two calendar years. Please indicate the commercial organization(s) with which you have/had affiliations, and briefly explain what connection you have/had with the organization. You must disclose this information to your audience

I DO NOT have an affiliation

Speakers who have no involvement with industry should inform the audience that they cannot identify any conflict of interest.

Affliation(s)

A: I am a member of an Advisory Board or equivalent with a commercial organization.

Yes

Company/Organization

ALK, Anergis, Biomay, ASIT Biotech, Adiga, UCB

Details

Consultancies with manufacturers of allergy vaccines

B: I am a member of a Speakers bureau.

No

C: I have received payment from a commercial organization. (including gifts or other consideration or ‘in kind’ compensation)

Yes

Company/Organization

ALK, Anergis, Adiga, Biomay, ASIT Biotech, UCB

Details

Consultancy payments

D: I have received a grant(s) or an honorarium from a commercial organization

Yes

Company/Organization

ALK, GSK

Details

Rsearch support

F: I hold investments in a pharmaceutical organization, medical devices company or communications firm.

No

G: I am currently participating in or have participated in a clinical trial within the past two years.

Yes

Company/Organization

Immune Tolerance Network.

Details

GRASS trial

DISCLOSURE/CONFLICT OF INTEREST DECLARATION

Acknowledgment:

I acknowledge that the above information is accurate and I understand that this information will be publicly available.

Name

Stephen Duirham

Signature

Entry Date

June 27, 2018